Prattes, Juergen; Wauters, Joost; Giacobbe, Daniele Roberto; Salmanton-García, Jon; Maertens, Johan; Bourgeois, Marc; Reynders, Marijke; Rutsaert, Lynn; Van Regenmortel, Niels; Lormans, Piet; Goldman, Gustavo Henrique 
Source: Clinical Microbiology and Infection. Unidade: FCFRP
Subjects: COVID-19, UNIDADES DE TERAPIA INTENSIVA, DOENÇA PULMONAR (ESPECIALIDADE), DOENÇAS INFECCIOSAS, FUNGOS, MICOLOGIA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRATTES, Juergen et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients - a multinational observational study by the European Confederation of Medical Mycology. Clinical Microbiology and Infection, v. 28, n. 4, p. 580-587, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.cmi.2021.08.014. Acesso em: 27 nov. 2025.APA
Prattes, J., Wauters, J., Giacobbe, D. R., Salmanton-García, J., Maertens, J., Bourgeois, M., et al. (2022). Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients - a multinational observational study by the European Confederation of Medical Mycology. Clinical Microbiology and Infection, 28( 4), 580-587. doi:10.1016/j.cmi.2021.08.014NLM
Prattes J, Wauters J, Giacobbe DR, Salmanton-García J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, Goldman GH. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients - a multinational observational study by the European Confederation of Medical Mycology [Internet]. Clinical Microbiology and Infection. 2022 ; 28( 4): 580-587.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.cmi.2021.08.014Vancouver
Prattes J, Wauters J, Giacobbe DR, Salmanton-García J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, Goldman GH. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients - a multinational observational study by the European Confederation of Medical Mycology [Internet]. Clinical Microbiology and Infection. 2022 ; 28( 4): 580-587.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.cmi.2021.08.014
